• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

特刊：“地中海贫血的新兴治疗方法与策略：迈向管理的新时代”

Special Issue: "Emerging Therapies and Strategies in Thalassemia: Toward a New Era in Management".

作者信息

Ricchi Paolo, Forni Gian Luca

机构信息

Center for Rare Red Blood Cell Diseases, AORN A. Cardarelli, 80131 Naples, Italy.

Center for Congenital Anemias and Iron Dysmetabolism, Galliera Hospital, 16128 Genoa, Italy.

出版信息

J Clin Med. 2022 Sep 1;11(17):5175. doi: 10.3390/jcm11175175.

DOI:10.3390/jcm11175175
PMID:36079104
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9457055/
Abstract

This Special Issue on "Emerging Therapies and Strategies in Thalassemia: Toward a New Era in management" aims to update researchers and clinicians regarding the field of thalassemia syndromes [...].

摘要

本期关于“地中海贫血的新兴治疗方法与策略：迈向管理新时代”的特刊旨在向研究人员和临床医生介绍地中海贫血综合征领域的最新情况[...]。

相似文献

1
Special Issue: "Emerging Therapies and Strategies in Thalassemia: Toward a New Era in Management".特刊：“地中海贫血的新兴治疗方法与策略：迈向管理的新时代”
J Clin Med. 2022 Sep 1;11(17):5175. doi: 10.3390/jcm11175175.
2
Emerging therapies in β-thalassemia: toward a new era in management.β-地中海贫血症的新兴疗法：管理新时代的到来。
Expert Opin Emerg Drugs. 2020 Jun;25(2):113-122. doi: 10.1080/14728214.2020.1752180. Epub 2020 Apr 15.
3
Erythropoiesis in lower-risk myelodysplastic syndromes and beta-thalassemia.低危骨髓增生异常综合征和β-地中海贫血症中的红细胞生成。
Blood Rev. 2023 May;59:101039. doi: 10.1016/j.blre.2022.101039. Epub 2022 Dec 22.
4
Emerging Therapies in β-Thalassemia.β-地中海贫血的新兴治疗方法。
Hematol Oncol Clin North Am. 2023 Apr;37(2):449-462. doi: 10.1016/j.hoc.2022.12.010.
5
A new era in iron chelation therapy: the design of optimal, individually adjusted iron chelation therapies for the complete removal of iron overload in thalassemia and other chronically transfused patients.铁螯合疗法的新时代：设计最佳的、个体化调整的铁螯合疗法，以完全清除地中海贫血和其他长期输血患者的铁过载。
Hemoglobin. 2009;33(5):332-8. doi: 10.3109/03630260903217182.
6
Update on thalassemia.地中海贫血最新进展
Pediatr Rev. 1992 Feb;13(2):55-62. doi: 10.1542/pir.13-2-55.
7
An Expert Overview on Therapies in Non-Transfusion-Dependent Thalassemia: Classical to Cutting Edge in Treatment.非输血依赖型地中海贫血治疗的专家综述：从经典到前沿治疗。
Hemoglobin. 2023 Nov;47(2):56-70. doi: 10.1080/03630269.2022.2158099. Epub 2023 Jun 16.
8
Recent advancements in glucose dysregulation and pharmacological management of osteoporosis in transfusion-dependent thalassemia (TDT): an update of ICET-A (International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescence Medicine).近年来，葡萄糖失调和骨质疏松症的药物治疗在输血依赖型地中海贫血（TDT）中的进展：ICET-A（地中海贫血和青春期医学内分泌学家国际网络）的更新。
Acta Biomed. 2023 Jun 14;94(3):e2023178. doi: 10.23750/abm.v94i3.14805.
9
Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series.β-地中海贫血患者铁过载的管理：基于病例系列的临床实践更新。
Int J Mol Sci. 2020 Nov 20;21(22):8771. doi: 10.3390/ijms21228771.
10
Gonadal dysfunction in adult male patients with thalassemia major: an update for clinicians caring for thalassemia.重型地中海贫血成年男性患者的性腺功能障碍：给地中海贫血护理临床医生的最新资讯
Expert Rev Hematol. 2017 Dec;10(12):1095-1106. doi: 10.1080/17474086.2017.1398080. Epub 2017 Nov 2.

本文引用的文献

1
Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia?铁调素调节在新兴的地中海贫血治疗方法中起作用吗？
J Clin Med. 2022 Aug 30;11(17):5119. doi: 10.3390/jcm11175119.
2
Safety and Efficacy of the New Combination Iron Chelation Regimens in Patients with Transfusion-Dependent Thalassemia and Severe Iron Overload.新型联合铁螯合方案用于依赖输血的地中海贫血和严重铁过载患者的安全性和有效性
J Clin Med. 2022 Apr 3;11(7):2010. doi: 10.3390/jcm11072010.
3
Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE) for the Management of Endocrine Complications in Patients with Haemoglobinopathies.意大利地中海贫血和血红蛋白病协会（SITE）关于血红蛋白病患者内分泌并发症管理的良好临床实践。
J Clin Med. 2022 Mar 25;11(7):1826. doi: 10.3390/jcm11071826.
4
Hearing Loss in Beta-Thalassemia: Systematic Review.β地中海贫血中的听力损失：系统评价
J Clin Med. 2021 Dec 25;11(1):102. doi: 10.3390/jcm11010102.
5
Setting for "Normal" Serum Ferritin Levels in Patients with Transfusion-Dependent Thalassemia: Our Current Strategy.输血依赖型地中海贫血患者“正常”血清铁蛋白水平的设定：我们目前的策略
J Clin Med. 2021 Dec 20;10(24):5985. doi: 10.3390/jcm10245985.
6
The Link of Pancreatic Iron with Glucose Metabolism and Cardiac Iron in Thalassemia Intermedia: A Large, Multicenter Observational Study.中间型地中海贫血患者胰腺铁与葡萄糖代谢及心脏铁的关联：一项大型多中心观察性研究
J Clin Med. 2021 Nov 26;10(23):5561. doi: 10.3390/jcm10235561.